Heart Transplantation for Early-Onset Anthracycline-Induced Cardiomyopathy Within 5 Months of Chemotherapy Completion.

Kaskinen, Anu K; Helle, Emmi; Pihkala, Jaana; Jahnukainen, Timo; Kanerva, Jukka; Mäyränpää, Mikko I; Lemström, Karl; Mattila, Ilkka; Ojala, Tiina.

Afiliação

Kaskinen AK; New Children's Hospital and Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Helle E; New Children's Hospital and Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Pihkala J; Stem Cells and Metabolism Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Jahnukainen T; New Children's Hospital and Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Kanerva J; New Children's Hospital and Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Mäyränpää MI; New Children's Hospital and Pediatric Research Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Lemström K; Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Mattila I; Heart and Lung Center, Cardiac Surgery, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Ojala T; Transplantation Laboratory, Haartman Institute, University of Helsinki, Helsinki, Finland.

JACC Case Rep ; 3(15): 1677-1679, 2021 Nov 03.

Article em En | MEDLINE | ID: mdl-34766017

Palavras-chave

ACM, anthracycline-induced cardiomyopathy; EF, ejection fraction; EMB, endomyocardial biopsy; FS, fractional shortening; HF, heart failure; HTx, heart transplantation; LV, left ventricle/ventricular; acute heart failure; cancer; cardiac transplantation; cardiomyopathy; pediatric surgery

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article